We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
The Packaging Academy has been organized by West in Asia Pacific for the past 5 years, beginning in 2015, and serves as a valued training platform for our customers in injectable packaging both in the areas of containment and delivery systems.
Hyderabad, India Event
In addition to the technical topics, the evolving regulatory concerns were also touched upon. This year, we extended the Packaging Academy to include Korea where West has expanded the presence with a new sales office. We have also extended our reach to India, in both Hyderabad and Ahmedabad.
Beijing, China Event
Some of the main topics covered were:
The courses were not restricted to West’s technical experts, and included technical specialists from the glass manufacturers in India and experts from the Shandong Quality Inspection Center for Medical Device in China to ensure we presented a holistic perspective of the relevant subjects to the participants.
The Packaging Academy has hosted more than 600 customers in the Asia Pacific region since its launch in 2015. In 2019, more than 300 participants were certified and have successfully completed the Packaging Academy courses. As noted by SokTiang Koh, VP of Scientific Affairs & Technical Customer Services for the Asia Pacific region at West, “The Packaging Academy is well-recognized by our customers and the continual increase in participation year by year is invaluable in West’s drive to be the customers’ scientific destination”.
<p>In Parts 1 and 2 of this five-part blog series on West’s inaugural Corporate Responsibility Report, we focused on Compliance and Ethics Programs, and Philanthropic efforts.</p><p>At West, we recognize and value the spectrum of people who make up our Company. It is a key to our success. Below is the third part of this five-part series reviewing West’s Diversity measures.</p>
Protein-based therapeutics are examples of the advancement of modern medicine and a revolution in drug discovery. Monoclonal antibodies (mAbs) account for the majority of biologic FDA approvals, and due to their low bioavailability by oral delivery means, they necessitate a shift to parenteral delivery. Hence, mAbs are typically packaged and stored in liquid or lyophilized format in glass vials, prefilled syringes, or cartridges for later injection.<br />
Westpharma.com has been upgraded! The new, mobile-friendly site offers easier navigation, intuitive design and enhanced searchability. The new site is mobile-friendly, and can be easily viewed and navigated from phones and tablets.
West Pharmaceutical Services, Inc. today announced that Eric M. Green has been appointed the company’s Chief Executive Officer, succeeding Donald E. Morel, Jr., Ph.D., current Chairman and CEO. Eric Green will join West and take on his new responsibilities on April 24, 2015.
Administration of cell therapy drug products requires the delivery of cell suspensions without loss of function or viability. Cells must be transferred aseptically from their original container closure system to the administration system by infusion. However, the common transfer practice of using needles and syringes to pierce vial stoppers to retrieve contents poses a risk, namely needle-stick injury to clinicians.
English
Chinese
